Skip to main content

Membranoproliferative Glomerulonephritis and C3 Glomerulopathy

  • Chapter
  • First Online:
Practical Nephrology

Abstract

The terms membranoproliferative glomerulonephritis (MPGN) and mesangiocapillary glomerulonephritis (MCGN) are interchangeable and refer to the light microscopic appearances of cellular proliferation in the mesangial regions of the glomeruli, with expansion of both cells and mesangial matrix, accompanied by thickening of the glomerular capillary walls. Rather than being a specific disease, MPGN is a morphological pattern which is associated with a wide range of distinct (and usually systemic) diseases. Recent developments in the understanding of these conditions emphasise the importance of establishing underlying disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Complement haemolytic activity: patient serum across a range of dilutions is used to lyse antibody-coated sheep erythrocytes. Lack of haemolysis at a given dilution suggests deficiency of complement component(s).

References

  1. Habib R, Michielsen P, et al. Clinical, microscopic and electron microscopic data in the nephrotic syndrome of unknown origin. In: Wolstenholme GEW, Cameron MP, editors. Ciba foundation symposium – renal biopsy: clinical and pathological significance. Chichester: Wiley; 1961. p. 70–102.

    Google Scholar 

  2. Little MA, Dupont P, et al. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69(3):504–11.

    Article  CAS  PubMed  Google Scholar 

  3. Servais A, Fremeaux-Bacchi V, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007;44(3):193–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Walker PD, Ferrario F, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol. 2007;20(6):605–16.

    Article  PubMed  Google Scholar 

  5. Abdurrahman MB, Aikhionbare HA, et al. Clinicopathological features of childhood nephrotic syndrome in northern Nigeria. Q J Med. 1990;75(278):563–76.

    CAS  PubMed  Google Scholar 

  6. Covic A, Schiller A, et al. Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant. 2006;21(2):419–24.

    Article  PubMed  Google Scholar 

  7. Hanko JB, Mullan RN, et al. The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant. 2009;24(10):3050–4.

    Article  PubMed  Google Scholar 

  8. Woo KT, Chan CM, et al. The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decades. Clin Nephrol. 2010;74(5):372–83.

    PubMed  Google Scholar 

  9. Cicardi M, Cesana B, et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat. 2000;7(2):138–43.

    Article  CAS  PubMed  Google Scholar 

  10. Bonnet F, Pineau JJ, et al. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. J Rheumatol. 2003;30(9):2005–10.

    PubMed  Google Scholar 

  11. Matignon M, Cacoub P, et al. Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine. 2009;88(6):341–8.

    Article  PubMed  Google Scholar 

  12. D’Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54(2):650–71.

    PubMed  Google Scholar 

  13. Levine A. Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Kidney Int Suppl. 1999;70:S41–6.

    Google Scholar 

  14. Tarshish P, Bernstein J, et al. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone–a report of the International Study of Kidney Disease in Children. Pediatr Nephrol. 1992;6(2):123–30.

    Article  CAS  PubMed  Google Scholar 

  15. Howie AJ. Handbook of renal biopsy pathology. 2nd ed. New York: Springer; 2008.

    Book  Google Scholar 

Further Reading

  • Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011;31(4):341–8.

    Article  CAS  PubMed  Google Scholar 

  • Pickering M, Cook HT. Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens. 2011;20(3):271–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel P. Gale MA, MBBChir, MRCP(UK) PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Gale, D.P., Owen-Casey, M. (2014). Membranoproliferative Glomerulonephritis and C3 Glomerulopathy. In: Harber, M. (eds) Practical Nephrology. Springer, London. https://doi.org/10.1007/978-1-4471-5547-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5547-8_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5546-1

  • Online ISBN: 978-1-4471-5547-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics